These data suggest a that substance P and its antagonists may represent clinically valuable entities for translation towards risk stratification, early diagnosis, prevention, and treatment of postoperative dementia in hip fracture patients and therefore merit further investigation. The gene discussed is TAC1; the disease is dementia.